leukocytes

Cell therapyexperimental

White blood cells, also called immune cells or immunocytes, are cells of the immune system that are involved in protecting the body against both infectious disease and foreign entities. White blood cells are generally larger than red blood cells. They include three main subtypes: granulocytes, lymphocytes and monocytes. — Wikipedia

Clinical trial activity

16 trials · 27 clinical orgs · 0 marketing orgs

Phase 1
7
Phase 2
7
Phase 3
2
Phase 4
1

Earliest trial started Aug 6, 2003 (NCT00066417)

Timeline

2000s

  1. Jan 1, 2003

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2008

    Earliest Phase 1 Sponsor(trial)

2010s

  1. Jan 1, 2011

    Earliest Phase 3 Sponsor(trial)

Indications

Approved for

Mechanism of action

  • leukocytesTissue restoration

    leukocytes tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • curexcell
  • donor leukocyte
  • donor leukocytes
  • leucocytes
  • leukocyte
  • leukocyte
  • leukocytes

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06529731Phase 2Aug 22, 2024Amgen, Food and Drug Administration, University of Pittsburgh
NCT04758702Phase 1Feb 24, 2021University of Kentucky
NCT03672669N/ANov 5, 2017Near East University, Turkey
NCT03124329N/AMay 1, 2017University of Southern California
NCT02923700Phase 4Sep 1, 2016University of Bologna
NCT02869204N/ASep 1, 2016University of Copenhagen
NCT02325063N/ADec 1, 2015Centre Hospitalier Universitaire de Nīmes
NCT02130310Phase 3May 1, 2014Barry University, MacroCure Ltd., St. Luke's-Roosevelt Hospital Center, University of Miami
NCT02923310Phase 1/Phase 2 (Phase 2)Nov 1, 2013University of Campinas
NCT01956630Phase 1/Phase 2 (Phase 2)Sep 1, 2013People's Liberation Army of China
NCT01369368Phase 1/Phase 2 (Phase 2)Aug 1, 2013University of Bergen
NCT01390311Phase 1Apr 1, 2012National Cancer Institute (NCI), Washington University in St. Louis
NCT02493283Phase 1Sep 1, 2011University of Greifswald
NCT01421966Phase 3Aug 1, 2011Amarex Clinical Research, ARANZ Medical, Department of Veteran Affairs, ICON, MacroCure Ltd.
NCT00718250Phase 1May 1, 2008Elimination of Leukaemia Fund, Leukemia Research Foundation, University of London
NCT00066417Phase 2Aug 6, 2003National Heart, Lung, and Blood Institute (NHLBI)
Showing 16 of 16 trials
Page 1 / 1

Organizations

Research & Development (27)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
MacroCure Ltd.For profit2212011
Amarex Clinical ResearchFor profit1012011
AmgenFor profit1012024
ARANZ MedicalFor profit1012011
Barry UniversityAcademic/Hospital1012014
Centre Hospitalier Universitaire de NīmesAcademic/Hospital1112015
Department of Veteran AffairsGovernment1012011
Elimination of Leukaemia FundAcademic/Hospital1012008
Food and Drug AdministrationGovernment1012024
ICONFor profit1012011
Leukemia Research FoundationAcademic/Hospital1012008
National Cancer Institute (NCI)Government1012012
National Heart, Lung, and Blood Institute (NHLBI)Government1112003
Near East University, TurkeyAcademic/Hospital1112017
People's Liberation Army of ChinaGovernment1112013
St. Luke's-Roosevelt Hospital CenterAcademic/Hospital1012014
University of BergenAcademic/Hospital1112013
University of BolognaAcademic/Hospital1112016
University of CampinasAcademic/Hospital1112013
University of CopenhagenAcademic/Hospital1112016
27 organizations
Page 1 / 2